Does HRT change intraocular pressure in postmenopausal women?
We aimed to investigate the changes of intraocular pressure in menopause patients with the use of hormone replacement therapy (HRT). Totally 137 postmenopausal women were evaluated in the study. 61 of them were under the treatment of HRT due to the menopausal symptoms. 76 women did not receive treatment. Intraocular pressure (IOP) was measured with Goldmann tonometer both groups. In the HRT treatment group (study group), mean values of IOP for 2 eyes in the first visits was 15.4±1.7 mmHg and 13.9 ± 1.4 mmHg after 6 months use of HRT, respectively (p<0.05). In the non-HRT group (control group) mean values of IOP for 2 eyes in the first visits was 14.4 ± 1.4 mmHg and 14.3 ± 1.4 mmHg after six months, respectively (p?0.05). HRT use and regular measurement of IOP regularly seems to prevents to reduce the risk of glaucoma in these patients, unless there are strong evidence that glaucoma does not occur in women on HRT.
___
1. Coleman AL, Brigatti L. The glaucomas. Minerva Med 2001; 92: 365-379.2. Hutchinson CV, Walker JA, Davidson C. Oestrogen, ocular function and low-level vision: a review. J Endocrinol 2014; 223(2): 9-18.
3. Tint NL, Alexander P, Tint KM, et al. Hormone therapy and intraocular pressure in nonglaucomatous eyes. Menopause 2010; 17: 157- 160.
4. Russo R, Cavaliere F, Watanabe C, et al. 17 Betaestradiol prevents retinal ganglion cell loss induced by acute rise of intraocular pressure in rat. Prog Brain Res 2008; 173: 583-590.
5. Weinreb RN, Khaw PT. Primary open-angle glaucoma. Lancet 2004; 363: 1711-1720.
6. Ogueta SB, Schwartz SD, Yamashita CK, Farber DB. Estrogen receptor in the human eye: influence of gender and age on gene expression. Invest Ophthalmol Vis Sci 1999; 40: 1906-1911.
7. Vajaranant TS, Maki PM, Pasquale LR, et al. Effects of Hormone Therapy on Intraocular Pressure: The Women's Health Initiative-Sight Exam Study. Am J Ophthalmol 2016; 165: 115- 124.
8. Toker E, Yenice O, Akpinar I, Aribal E, Kazokoglu H. The influence of sex hormones on ocular blood flow in women. Acta Ophthalmol Scand 2003; 81: 617-624.
9. Harris A, Rechtman E, Siesky B, et al. The role of optic nerve blood flow in the pathogenesis of glaucoma. Ophthalmol Clin North Am 2005; 18: 345-353.
10. Feke GT, Pasquale LR. Retinal blood flow response to posture change in glaucoma patients compared with healthy subjects. Ophthalmology 2008; 115: 246-252.
11. Kang JH, Wiggs JL, Rosner BA, et al. Endothelial nitric oxide syntheses gene variants and primary open-angle glaucoma: interactions with sex and postmenopausal hormone use. Invest Ophthalmol Vis Sci 2010; 51: 971-979.
12. Ohmichi M, Kanda Y, Hisamoto K, et al. Rapid changes of flow-mediated dilatation after surgical menopause. Maturitas 2003; 44: 125-131.
13. Deschenes MC, Descovich D, Moreau M, et al. Postmenopausal hormone therapy increases retinal blood flow and protects the retinal nerve fiber layer. Invest Ophthalmol Vis Sci 2010; 51: 2587-2600.
14. Altintas O, Caglar Y, Yuksel N, Demirci A, Karabas L. 2004 The effects of menopause and hormone replacement therapy on quality and quantity of tear, intraocular pressure and ocular blood flow. International journal of ophthalmology 2004; 218: 120-129.
15. Battaglia C, Mancini F, Regnani G, Persico N, Volpe A, De Aloysio D. Hormone therapy and ophthalmic artery blood flow changes in women with primary open-angle glaucoma. Menopause 2004; 11: 69-77.
16. Qureshi IA.Intraocular pressure: association with menstrual cycle, pregnancy and menopause in apparently healthy women. Chin J Physiol 1995; 38: 229-234.
17. Lang Y, Lang N, Ben-Ami M, Garzozi H. The effects of hormone replacement therapy (HRT) on the human eye. Harefuah 2002; 141: 287-291.
18. Coksuer H, Ozcura F, Oghan F, Haliloğlu B, Coksuer C. Climacteric 2011; 14: 482-487.
19. Guaschino S, Grimaldi E, Sartore A, et al. Visual function in menopause: The role of hormone replacement therapy. Menopause 2003; 10: 53- 57.
20. Abramov Y, Borik S, Yahalom C, et al. Does postmenopausal hormone replacement affect intraocular pressure? J Glaucoma 2005; 14: 271- 275.
21. Uncu G, Avcı R, Uncu Y, Kaymaz C, Develioğlu O. The effects of different hormone replacement therapy regimens on tear fonction, intraocular pressure and lens opacity. Gynecol Endocrinol 2006; 22; 501-505.
22. Guedes G, Tsai JC, Loewen NA. Glaucoma and aging. Curr Aging Sci 2011; 4: 110-117.
23. Patel K, Patel S. Angle-closure glaucoma. Dis Mon 2014; 60: 254-262.
- ISSN: 1301-0883
- Başlangıç: 1996
- Yayıncı: ERBİL KARAMAN
Sayıdaki Diğer Makaleler
Does Chiari’s Network affect atrial septal defect measurement?
Fatma Nur GÜMRÜKCÜOĞLU, Hasan Ali GÜMRÜKCÜOĞLU
Mean platelet volume: A simple tool for early risk stra- tification of pulmonary embolism
Ayşegül ŞENTÜRK, ASİYE KANBAY, Serpil ERDOĞAN, Habibe HEZER, HATİCE CANAN HASANOĞLU, Hatice KILIÇ, Tuba ÖĞÜT
Ultrasound practice in emergency medicine
Tülin TÜRKÖZÜ, SAVAŞ GÜNER, MEHMET FETHİ CEYLAN, Necip GÜVEN
MEHMET BERKÖZ, Oruc ALLAHVERDİYEV
Bilateral intraorbital hemorrhage with factor XIII deficiency after strabismus surgery
ERBİL SEVEN, MUHAMMED BATUR, Adnan ÇİNAL, TEKİN YAŞAR, AHMET DEMİROK
Min Wei CHİNG, Chee Ping CHONG
Ramesh KUMAR3, Salina HUSAİN1, Nik Mohd HUSSİN, Farah Dayana ZAHEDİ1
Does HRT change intraocular pressure in postmenopausal women?
SAİT COŞKUN ÖZCAN, Harun Egemen TOLUNAY, DENİZ ÖZARSLAN ÖZCAN, FATİH MEHMET ADIBELLİ